Note 21. Research and development
Research and Development consists of the following:
|Year ended December 31,|
|Research and development expenses, net of capitalized development expenses||41,392||50,417|
|Amortization of capitalized development expenses||9,957||10,893|
|Research and development grants and credits||(1,035)||(905)|
|Total research and development expenses||50,314||60,405|
|Impairment of capitalized development expenses||7,761||893|
The impairment of capitalized development expenses are primarily related to development of new hardware for which the customers demand has shifted out in time, and purchased technology which became obsolete.
The Company’s operations in the Netherlands, Germany and the United States receive research and development grants and credits from various sources.